BOGLE INVESTMENT MANAGEMENT L P /DE/ - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 147 filers reported holding SANGAMO THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOGLE INVESTMENT MANAGEMENT L P /DE/ ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$462,000
-63.2%
29,636
-55.2%
0.73%
+671.6%
Q1 2018$1,256,000
-92.1%
66,111
-93.2%
0.10%
-91.8%
Q4 2017$15,844,000
+1.4%
966,128
-7.2%
1.16%
+9.4%
Q3 2017$15,622,000
+349.7%
1,041,478
+163.7%
1.06%
+320.6%
Q2 2017$3,474,000394,8770.25%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
FIC CAPITAL INC 875,284$2,670,0001.34%
NEXTHERA CAPITAL LP 503,000$1,534,0000.90%
Opaleye Management Inc. 400,000$1,220,0000.72%
WASATCH ADVISORS LP 7,256,260$22,132,0000.33%
Cormorant Asset Management, LP 650,000$1,983,0000.27%
Sicart Associates LLC 101,950$311,0000.22%
Baker Brothers Advisors 4,055,876$12,370,0000.12%
Leisure Capital Management 43,008$131,0000.12%
Piermont Capital Management Inc. 165,569$505,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 837,963$2,556,0000.10%
View complete list of SANGAMO THERAPEUTICS INC shareholders